5/9/2013 6:53:12 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CALGARY, May 9, 2013 /PRNewswire/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced its financial results and operational highlights for the quarter ended March 31, 2013.
"We recently reported positive data from our squamous cell carcinoma of the lung study both with respect to the study's primary endpoint and tumour shrinkage, which supports the conduct of further studies in this indication," said Dr. Brad Thompson, President and CEO of Oncolytics.
Help employers find you! Check out all the jobs and post your resume.
comments powered by